Molecular Partners Ag (MOLN) Net Margin Growth (3y) (2023 - 2026)
Molecular Partners Ag (MOLN) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | -5,319.00 |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,782.00 |
| Dec 31, 2025 | 14.39 Mn |
| Sep 30, 2025 | -9,831.00 |
| Jun 30, 2025 | -7,937.00 |
| Mar 31, 2025 | -10,392.00 |
| Dec 31, 2024 | 109.76 Mn |
| Sep 30, 2024 | 34,854.00 |
| Jun 30, 2024 | -97.24 Mn |
| Mar 31, 2024 | -41,383.00 |
| Dec 31, 2023 | -91,000.00 |
| Sep 30, 2023 | -45,041.00 |